Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase

Nature Chemical Biology
Catarina CoelhoMaria João Romão

Abstract

Aldehyde oxidase (AOX) is a xanthine oxidase (XO)-related enzyme with emerging importance due to its role in the metabolism of drugs and xenobiotics. We report the first crystal structures of human AOX1, substrate free (2.6-Å resolution) and in complex with the substrate phthalazine and the inhibitor thioridazine (2.7-Å resolution). Analysis of the protein active site combined with steady-state kinetic studies highlight the unique features, including binding and substrate orientation at the active site, that characterize human AOX1 as an important drug-metabolizing enzyme. Structural analysis of the complex with the noncompetitive inhibitor thioridazine revealed a new, unexpected and fully occupied inhibitor-binding site that is structurally conserved among mammalian AOXs and XO. The new structural insights into the catalytic and inhibition mechanisms of human AOX that we now report will be of great value for the rational analysis of clinical drug interactions involving inhibition of AOX1 and for the prediction and design of AOX-stable putative drugs.

References

Jan 27, 1998·Pharmacy World & Science : PWS·C Beedham
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·C EnrothE F Pai
Feb 24, 2001·Archives of Biochemistry and Biophysics·C A TempleK V Rajagopalan
Dec 19, 2003·Journal of Clinical Pharmacology·R Scott ObachChristine Beedham
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ken OkamotoTakeshi Nishino
Jun 24, 2004·Acta Crystallographica. Section D, Biological Crystallography·Robert SchwarzenbacherLukasz Jaroszewski
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Mar 24, 2005·Microbiological Research·Laxmi Rani BasuSujata G Dastidar
Apr 5, 2005·Acta Crystallographica. Section D, Biological Crystallography·Airlie J McCoyRandy J Read
Dec 22, 2005·Acta Crystallographica. Section D, Biological Crystallography·Philip Evans
May 5, 2006·The Journal of Biological Chemistry·Mineko TeraoEnrico Garattini
May 17, 2006·Drug Metabolism and Pharmacokinetics·Shigeyuki KitamuraShigeru Ohta
Dec 11, 2007·Cellular and Molecular Life Sciences : CMLS·E GarattiniM Terao
May 20, 2009·Dalton Transactions : an International Journal of Inorganic Chemistry·Maria João Romão
Dec 30, 2009·Human Genomics·Enrico GarattiniMineko Terao
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Sep 22, 2010·Journal of Medicinal Chemistry·David C PrydeThien-Duc Tran
Mar 25, 2011·Drug Metabolism Reviews·Enrico Garattini, Mineko Terao
Jun 28, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Martin MahroSilke Leimkühler
Sep 24, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·John T Barr, Jeffrey P Jones
Dec 8, 2011·Journal of the American Chemical Society·Hiroshi IshikitaEmil F Pai
Jan 27, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tobias HartmannSilke Leimkühler
Feb 18, 2012·Expert Opinion on Drug Metabolism & Toxicology·Enrico Garattini, Mineko Terao
Mar 27, 2012·International Journal of Antimicrobial Agents·Leonard Amaral, Miguel Viveiros
Sep 29, 2012·The Journal of Biological Chemistry·Catarina CoelhoMaria João Romão
Jul 17, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cexiong FuHui Zhang
Aug 16, 2013·Angewandte Chemie·Florian SchlaudererKarl-Peter Hopfner
Jan 1, 2014·Structure·Pravas Kumar BaralMichael N G James
Jan 29, 2014·Chemical Reviews·Russ HillePartha Basu

❮ Previous
Next ❯

Citations

Feb 28, 2016·Archives of Toxicology·Mineko TeraoEnrico Garattini
Sep 13, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Angela HayesFlorence I Raynaud
Jan 18, 2017·Expert Opinion on Drug Discovery·Mohammad-Reza Rashidi, Somaieh Soltani
Jan 28, 2017·Current Opinion in Chemical Biology·Maria João RomãoSilke Leimkühler
Jan 11, 2018·Journal of Biochemistry·Hiroyuki UchidaMasaya Oki
May 12, 2018·FEBS Letters·Daniel Bender, Guenter Schwarz
Nov 2, 2018·European Journal of Drug Metabolism and Pharmacokinetics·Farnaz Deris-AbdolahpourMohammad-Reza Rashidi
Sep 14, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jiang Wei ZhangJi Yue Jeff Zhang
May 21, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gökhan KücükgözeSilke Leimkühler
Jul 11, 2019·The Journal of Pharmacology and Experimental Therapeutics·Shiyan ChenAik Jiang Lau
Mar 8, 2020·The Journal of Biological Chemistry·Mineko TeraoSilke Leimkühler
Jun 1, 2019·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Christine Beedham
Feb 5, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Alessandro FotiSilke Leimkühler
Jun 15, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Robert S Foti, Deepak K Dalvie
Jan 16, 2019·Proceedings of the National Academy of Sciences of the United States of America·Jing ZhangDon B Gammon
Sep 25, 2019·Drug Metabolism Reviews·Narges CheshmazarMaryam Hamzeh-Mivehroud
Mar 5, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Rachel D CrouchJ Scott Daniels
Apr 5, 2017·Proceedings of the National Academy of Sciences of the United States of America·Susan LepriGabriele Cruciani
Jan 30, 2021·The Journal of Biological Chemistry·Mineko TeraoSilke Leimkühler
Mar 20, 2020·Journal of Medicinal Chemistry·Jihui ZhaoMingyue Zheng
May 5, 2021·Drug Metabolism Reviews·Nikhilesh V DhuriaJasleen K Sodhi
Jul 20, 2018·ACS Omega·Marco MontefioriLars Olsen
Aug 7, 2019·Journal of Medicinal Chemistry·Nenad ManevskiFrancesca Toselli
Apr 10, 2018·Journal of Chemical Theory and Computation·Pedro FerreiraMaria J Ramos
Jun 30, 2021·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Claudia Garrido, Silke Leimkühler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Drug Metabolism & Toxicology
Enrico Garattini, Mineko Terao
The Journal of Biological Chemistry
D EdmondsonV Massey
The Journal of Biological Chemistry
I FRIDOVICH, P HANDLER
© 2021 Meta ULC. All rights reserved